Global Infectious Disease Diagnostics Testing Market Research Report 2022

Market Analysis and Insights: Global Infectious Disease Diagnostics Testing Market

In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.

The global Infectious Disease Diagnostics Testing market size is projected to reach US$ 21090 million by 2028, from US$ 16500 million in 2021, at a CAGR of 3.5% during 2022-2028.

Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Disease Diagnostics Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Disease Diagnostics Testing market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Disease Diagnostics Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Disease Diagnostics Testing market.

Global Infectious Disease Diagnostics Testing Scope and Market Size

Infectious Disease Diagnostics Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Infectious Disease Diagnostics Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Molecular Diagnostic Test

POC Infectious Disease Diagnostics Test

Hospital

Academics Research

Others

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Abbott

bioMérieux

Diasorin

Roche Diagnostic

Beckman Coulter

Becton, Dickinson and Company

Bio-Rad Laboratories

Cavidi

Cepheid

Corgenix

Diaxonhit

Eiken Chemical

EMD Millipore

Epitope Diagnostic

EUROIMMUN

Gold Standard Diagnostics

Hologic

Immunetics

InBios International

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Molecular Diagnostic Test

1.2.3 POC Infectious Disease Diagnostics Test

1.3 Market by Application

1.3.1 Global Infectious Disease Diagnostics Testing Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Academics Research

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2.1 Global Infectious Disease Diagnostics Testing Market Perspective (2017-2028)

2.2 Infectious Disease Diagnostics Testing Growth Trends by Region

2.2.1 Infectious Disease Diagnostics Testing Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Infectious Disease Diagnostics Testing Historic Market Size by Region (2017-2022)

2.2.3 Infectious Disease Diagnostics Testing Forecasted Market Size by Region (2023-2028)

2.3 Infectious Disease Diagnostics Testing Market Dynamics

2.3.1 Infectious Disease Diagnostics Testing Industry Trends

2.3.2 Infectious Disease Diagnostics Testing Market Drivers

2.3.3 Infectious Disease Diagnostics Testing Market Challenges

2.3.4 Infectious Disease Diagnostics Testing Market Restraints

3.1 Global Top Infectious Disease Diagnostics Testing Players by Revenue

3.1.1 Global Top Infectious Disease Diagnostics Testing Players by Revenue (2017-2022)

3.1.2 Global Infectious Disease Diagnostics Testing Revenue Market Share by Players (2017-2022)

3.2 Global Infectious Disease Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Infectious Disease Diagnostics Testing Revenue

3.4 Global Infectious Disease Diagnostics Testing Market Concentration Ratio

3.4.1 Global Infectious Disease Diagnostics Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Diagnostics Testing Revenue in 2021

3.5 Infectious Disease Diagnostics Testing Key Players Head office and Area Served

3.6 Key Players Infectious Disease Diagnostics Testing Product Solution and Service

3.7 Date of Enter into Infectious Disease Diagnostics Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Type (2017-2022)

4.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2023-2028)

5.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Application (2017-2022)

5.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2023-2028)

6.1 North America Infectious Disease Diagnostics Testing Market Size (2017-2028)

6.2 North America Infectious Disease Diagnostics Testing Market Size by Country (2017-2022)

6.3 North America Infectious Disease Diagnostics Testing Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7.1 Europe Infectious Disease Diagnostics Testing Market Size (2017-2028)

7.2 Europe Infectious Disease Diagnostics Testing Market Size by Country (2017-2022)

7.3 Europe Infectious Disease Diagnostics Testing Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8.1 Asia-Pacific Infectious Disease Diagnostics Testing Market Size (2017-2028)

8.2 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Country (2017-2022)

8.3 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9.1 Latin America Infectious Disease Diagnostics Testing Market Size (2017-2028)

9.2 Latin America Infectious Disease Diagnostics Testing Market Size by Country (2017-2022)

9.3 Latin America Infectious Disease Diagnostics Testing Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10.1 Middle East & Africa Infectious Disease Diagnostics Testing Market Size (2017-2028)

10.2 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2017-2022)

10.3 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11.1 Abbott

11.1.1 Abbott Company Detail

11.1.2 Abbott Business Overview

11.1.3 Abbott Infectious Disease Diagnostics Testing Introduction

11.1.4 Abbott Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.1.5 Abbott Recent Development

11.2 bioMérieux

11.2.1 bioMérieux Company Detail

11.2.2 bioMérieux Business Overview

11.2.3 bioMérieux Infectious Disease Diagnostics Testing Introduction

11.2.4 bioMérieux Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.2.5 bioMérieux Recent Development

11.3 Diasorin

11.3.1 Diasorin Company Detail

11.3.2 Diasorin Business Overview

11.3.3 Diasorin Infectious Disease Diagnostics Testing Introduction

11.3.4 Diasorin Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.3.5 Diasorin Recent Development

11.4 Roche Diagnostic

11.4.1 Roche Diagnostic Company Detail

11.4.2 Roche Diagnostic Business Overview

11.4.3 Roche Diagnostic Infectious Disease Diagnostics Testing Introduction

11.4.4 Roche Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.4.5 Roche Diagnostic Recent Development

11.5 Beckman Coulter

11.5.1 Beckman Coulter Company Detail

11.5.2 Beckman Coulter Business Overview

11.5.3 Beckman Coulter Infectious Disease Diagnostics Testing Introduction

11.5.4 Beckman Coulter Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.5.5 Beckman Coulter Recent Development

11.6 Becton, Dickinson and Company

11.6.1 Becton, Dickinson and Company Company Detail

11.6.2 Becton, Dickinson and Company Business Overview

11.6.3 Becton, Dickinson and Company Infectious Disease Diagnostics Testing Introduction

11.6.4 Becton, Dickinson and Company Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.6.5 Becton, Dickinson and Company Recent Development

11.7 Bio-Rad Laboratories

11.7.1 Bio-Rad Laboratories Company Detail

11.7.2 Bio-Rad Laboratories Business Overview

11.7.3 Bio-Rad Laboratories Infectious Disease Diagnostics Testing Introduction

11.7.4 Bio-Rad Laboratories Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.7.5 Bio-Rad Laboratories Recent Development

11.8 Cavidi

11.8.1 Cavidi Company Detail

11.8.2 Cavidi Business Overview

11.8.3 Cavidi Infectious Disease Diagnostics Testing Introduction

11.8.4 Cavidi Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.8.5 Cavidi Recent Development

11.9 Cepheid

11.9.1 Cepheid Company Detail

11.9.2 Cepheid Business Overview

11.9.3 Cepheid Infectious Disease Diagnostics Testing Introduction

11.9.4 Cepheid Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.9.5 Cepheid Recent Development

11.10 Corgenix

11.10.1 Corgenix Company Detail

11.10.2 Corgenix Business Overview

11.10.3 Corgenix Infectious Disease Diagnostics Testing Introduction

11.10.4 Corgenix Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.10.5 Corgenix Recent Development

11.11 Diaxonhit

11.11.1 Diaxonhit Company Detail

11.11.2 Diaxonhit Business Overview

11.11.3 Diaxonhit Infectious Disease Diagnostics Testing Introduction

11.11.4 Diaxonhit Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.11.5 Diaxonhit Recent Development

11.12 Eiken Chemical

11.12.1 Eiken Chemical Company Detail

11.12.2 Eiken Chemical Business Overview

11.12.3 Eiken Chemical Infectious Disease Diagnostics Testing Introduction

11.12.4 Eiken Chemical Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.12.5 Eiken Chemical Recent Development

11.13 EMD Millipore

11.13.1 EMD Millipore Company Detail

11.13.2 EMD Millipore Business Overview

11.13.3 EMD Millipore Infectious Disease Diagnostics Testing Introduction

11.13.4 EMD Millipore Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.13.5 EMD Millipore Recent Development

11.14 Epitope Diagnostic

11.14.1 Epitope Diagnostic Company Detail

11.14.2 Epitope Diagnostic Business Overview

11.14.3 Epitope Diagnostic Infectious Disease Diagnostics Testing Introduction

11.14.4 Epitope Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.14.5 Epitope Diagnostic Recent Development

11.15 EUROIMMUN

11.15.1 EUROIMMUN Company Detail

11.15.2 EUROIMMUN Business Overview

11.15.3 EUROIMMUN Infectious Disease Diagnostics Testing Introduction

11.15.4 EUROIMMUN Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.15.5 EUROIMMUN Recent Development

11.16 Gold Standard Diagnostics

11.16.1 Gold Standard Diagnostics Company Detail

11.16.2 Gold Standard Diagnostics Business Overview

11.16.3 Gold Standard Diagnostics Infectious Disease Diagnostics Testing Introduction

11.16.4 Gold Standard Diagnostics Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.16.5 Gold Standard Diagnostics Recent Development

11.17 Hologic

11.17.1 Hologic Company Detail

11.17.2 Hologic Business Overview

11.17.3 Hologic Infectious Disease Diagnostics Testing Introduction

11.17.4 Hologic Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.17.5 Hologic Recent Development

11.18 Immunetics

11.18.1 Immunetics Company Detail

11.18.2 Immunetics Business Overview

11.18.3 Immunetics Infectious Disease Diagnostics Testing Introduction

11.18.4 Immunetics Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.18.5 Immunetics Recent Development

11.19 InBios International

11.19.1 InBios International Company Detail

11.19.2 InBios International Business Overview

11.19.3 InBios International Infectious Disease Diagnostics Testing Introduction

11.19.4 InBios International Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)

11.19.5 InBios International Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Key Players of Molecular Diagnostic Test

    Table 3. Key Players of POC Infectious Disease Diagnostics Test

    Table 4. Global Infectious Disease Diagnostics Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

    Table 5. Global Infectious Disease Diagnostics Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

    Table 6. Global Infectious Disease Diagnostics Testing Market Size by Region (2017-2022) & (US$ Million)

    Table 7. Global Infectious Disease Diagnostics Testing Market Share by Region (2017-2022)

    Table 8. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)

    Table 9. Global Infectious Disease Diagnostics Testing Market Share by Region (2023-2028)

    Table 10. Infectious Disease Diagnostics Testing Market Trends

    Table 11. Infectious Disease Diagnostics Testing Market Drivers

    Table 12. Infectious Disease Diagnostics Testing Market Challenges

    Table 13. Infectious Disease Diagnostics Testing Market Restraints

    Table 14. Global Infectious Disease Diagnostics Testing Revenue by Players (2017-2022) & (US$ Million)

    Table 15. Global Infectious Disease Diagnostics Testing Market Share by Players (2017-2022)

    Table 16. Global Top Infectious Disease Diagnostics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics Testing as of 2021)

    Table 17. Ranking of Global Top Infectious Disease Diagnostics Testing Companies by Revenue (US$ Million) in 2021

    Table 18. Global 5 Largest Players Market Share by Infectious Disease Diagnostics Testing Revenue (CR5 and HHI) & (2017-2022)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Infectious Disease Diagnostics Testing Product Solution and Service

    Table 21. Date of Enter into Infectious Disease Diagnostics Testing Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Infectious Disease Diagnostics Testing Market Size by Type (2017-2022) & (US$ Million)

    Table 24. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2017-2022)

    Table 25. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 26. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2023-2028)

    Table 27. Global Infectious Disease Diagnostics Testing Market Size by Application (2017-2022) & (US$ Million)

    Table 28. Global Infectious Disease Diagnostics Testing Revenue Market Share by Application (2017-2022)

    Table 29. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 30. Global Infectious Disease Diagnostics Testing Revenue Market Share by Application (2023-2028)

    Table 31. North America Infectious Disease Diagnostics Testing Market Size by Country (2017-2022) & (US$ Million)

    Table 32. North America Infectious Disease Diagnostics Testing Market Size by Country (2023-2028) & (US$ Million)

    Table 33. Europe Infectious Disease Diagnostics Testing Market Size by Country (2017-2022) & (US$ Million)

    Table 34. Europe Infectious Disease Diagnostics Testing Market Size by Country (2023-2028) & (US$ Million)

    Table 35. Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2017-2022) & (US$ Million)

    Table 36. Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2023-2028) & (US$ Million)

    Table 37. Latin America Infectious Disease Diagnostics Testing Market Size by Country (2017-2022) & (US$ Million)

    Table 38. Latin America Infectious Disease Diagnostics Testing Market Size by Country (2023-2028) & (US$ Million)

    Table 39. Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2017-2022) & (US$ Million)

    Table 40. Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2023-2028) & (US$ Million)

    Table 41. Abbott Company Detail

    Table 42. Abbott Business Overview

    Table 43. Abbott Infectious Disease Diagnostics Testing Product

    Table 44. Abbott Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 45. Abbott Recent Development

    Table 46. bioMérieux Company Detail

    Table 47. bioMérieux Business Overview

    Table 48. bioMérieux Infectious Disease Diagnostics Testing Product

    Table 49. bioMérieux Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 50. bioMérieux Recent Development

    Table 51. Diasorin Company Detail

    Table 52. Diasorin Business Overview

    Table 53. Diasorin Infectious Disease Diagnostics Testing Product

    Table 54. Diasorin Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 55. Diasorin Recent Development

    Table 56. Roche Diagnostic Company Detail

    Table 57. Roche Diagnostic Business Overview

    Table 58. Roche Diagnostic Infectious Disease Diagnostics Testing Product

    Table 59. Roche Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 60. Roche Diagnostic Recent Development

    Table 61. Beckman Coulter Company Detail

    Table 62. Beckman Coulter Business Overview

    Table 63. Beckman Coulter Infectious Disease Diagnostics Testing Product

    Table 64. Beckman Coulter Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 65. Beckman Coulter Recent Development

    Table 66. Becton, Dickinson and Company Company Detail

    Table 67. Becton, Dickinson and Company Business Overview

    Table 68. Becton, Dickinson and Company Infectious Disease Diagnostics Testing Product

    Table 69. Becton, Dickinson and Company Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 70. Becton, Dickinson and Company Recent Development

    Table 71. Bio-Rad Laboratories Company Detail

    Table 72. Bio-Rad Laboratories Business Overview

    Table 73. Bio-Rad Laboratories Infectious Disease Diagnostics Testing Product

    Table 74. Bio-Rad Laboratories Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 75. Bio-Rad Laboratories Recent Development

    Table 76. Cavidi Company Detail

    Table 77. Cavidi Business Overview

    Table 78. Cavidi Infectious Disease Diagnostics Testing Product

    Table 79. Cavidi Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 80. Cavidi Recent Development

    Table 81. Cepheid Company Detail

    Table 82. Cepheid Business Overview

    Table 83. Cepheid Infectious Disease Diagnostics Testing Product

    Table 84. Cepheid Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 85. Cepheid Recent Development

    Table 86. Corgenix Company Detail

    Table 87. Corgenix Business Overview

    Table 88. Corgenix Infectious Disease Diagnostics Testing Product

    Table 89. Corgenix Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 90. Corgenix Recent Development

    Table 91. Diaxonhit Company Detail

    Table 92. Diaxonhit Business Overview

    Table 93. Diaxonhit Infectious Disease Diagnostics TestingProduct

    Table 94. Diaxonhit Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 95. Diaxonhit Recent Development

    Table 96. Eiken Chemical Company Detail

    Table 97. Eiken Chemical Business Overview

    Table 98. Eiken Chemical Infectious Disease Diagnostics TestingProduct

    Table 99. Eiken Chemical Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 100. Eiken Chemical Recent Development

    Table 101. EMD Millipore Company Detail

    Table 102. EMD Millipore Business Overview

    Table 103. EMD Millipore Infectious Disease Diagnostics TestingProduct

    Table 104. EMD Millipore Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 105. EMD Millipore Recent Development

    Table 106. Epitope Diagnostic Company Detail

    Table 107. Epitope Diagnostic Business Overview

    Table 108. Epitope Diagnostic Infectious Disease Diagnostics TestingProduct

    Table 109. Epitope Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 110. Epitope Diagnostic Recent Development

    Table 111. EUROIMMUN Company Detail

    Table 112. EUROIMMUN Business Overview

    Table 113. EUROIMMUN Infectious Disease Diagnostics TestingProduct

    Table 114. EUROIMMUN Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 115. EUROIMMUN Recent Development

    Table 116. Gold Standard Diagnostics Company Detail

    Table 117. Gold Standard Diagnostics Business Overview

    Table 118. Gold Standard Diagnostics Infectious Disease Diagnostics TestingProduct

    Table 119. Gold Standard Diagnostics Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 120. Gold Standard Diagnostics Recent Development

    Table 121. Hologic Company Detail

    Table 122. Hologic Business Overview

    Table 123. Hologic Infectious Disease Diagnostics TestingProduct

    Table 124. Hologic Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 125. Hologic Recent Development

    Table 126. Immunetics Company Detail

    Table 127. Immunetics Business Overview

    Table 128. Immunetics Infectious Disease Diagnostics TestingProduct

    Table 129. Immunetics Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 130. Immunetics Recent Development

    Table 131. InBios International Company Detail

    Table 132. InBios International Business Overview

    Table 133. InBios International Infectious Disease Diagnostics TestingProduct

    Table 134. InBios International Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)

    Table 135. InBios International Recent Development

    Table 136. Research Programs/Design for This Report

    Table 137. Key Data Information from Secondary Sources

    Table 138. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Infectious Disease Diagnostics Testing Market Share by Type: 2021 VS 2028

    Figure 2. Molecular Diagnostic Test Features

    Figure 3. POC Infectious Disease Diagnostics Test Features

    Figure 4. Global Infectious Disease Diagnostics Testing Market Share by Application in 2021 & 2028

    Figure 5. Hospital Case Studies

    Figure 6. Academics Research Case Studies

    Figure 7. Others Case Studies

    Figure 8. Infectious Disease Diagnostics Testing Report Years Considered

    Figure 9. Global Infectious Disease Diagnostics Testing Market Size (US$ Million), Year-over-Year: 2017-2028

    Figure 10. Global Infectious Disease Diagnostics Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 11. Global Infectious Disease Diagnostics Testing Market Share by Region: 2021 VS 2028

    Figure 12. Global Infectious Disease Diagnostics Testing Market Share by Players in 2021

    Figure 13. Global Top Infectious Disease Diagnostics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics Testing as of 2021)

    Figure 14. The Top 10 and 5 Players Market Share by Infectious Disease Diagnostics Testing Revenue in 2021

    Figure 15. North America Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 16. North America Infectious Disease Diagnostics Testing Market Share by Country (2017-2028)

    Figure 17. United States Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 18. Canada Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 19. Europe Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 20. Europe Infectious Disease Diagnostics Testing Market Share by Country (2017-2028)

    Figure 21. Germany Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 22. France Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 23. U.K. Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 24. Italy Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 25. Russia Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 26. Nordic Countries Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 27. Asia-Pacific Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 28. Asia-Pacific Infectious Disease Diagnostics Testing Market Share by Region (2017-2028)

    Figure 29. China Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 30. Japan Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 31. South Korea Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 32. Southeast Asia Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 33. India Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 34. Australia Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 35. Latin America Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 36. Latin America Infectious Disease Diagnostics Testing Market Share by Country (2017-2028)

    Figure 37. Mexico Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 38. Brazil Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 39. Middle East & Africa Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 40. Middle East & Africa Infectious Disease Diagnostics Testing Market Share by Country (2017-2028)

    Figure 41. Turkey Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 42. Saudi Arabia Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 43. Abbott Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 44. bioMérieux Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 45. Diasorin Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 46. Roche Diagnostic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 47. Beckman Coulter Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 48. Becton, Dickinson and Company Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 50. Cavidi Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 51. Cepheid Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 52. Corgenix Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 53. Diaxonhit Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 54. Eiken Chemical Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 55. EMD Millipore Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 56. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 57. EUROIMMUN Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 58. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 59. Hologic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 60. Immunetics Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 61. InBios International Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)

    Figure 62. Bottom-up and Top-down Approaches for This Report

    Figure 63. Data Triangulation

    Figure 64. Key Executives Interviewed